_shane-van-gisbergen-still-learning-adjusting-to-ovals-in-xfinity-series.jpg "Shane van Gisbergen ‘still learning,’ adjusting to ovals in Xfinity Series from hp dhakawap com 18 shane photo angela islamic arabic Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1:0
👁 View: 235K times
✓ Published: 11-May-2024
👁 View: 235K times
✓ Published: 11-May-2024
Description:
Shane van Gisbergen discusses what he learns racing on ovals in the NASCAR Xfinity Series on a week-to-week basis.
Shane van Gisbergen discusses what he learns racing on ovals in the NASCAR Xfinity Series on a week-to-week basis.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_hsn-124-innovation-event-featuring-hp-electronics-09-18-2016-01-am.webp "HSN")
_hsn-124-tech-talk-featuring-hp-01-30-2021-10-pm.webp "HSNtv")
_shane-van-gisbergen-still-learning-adjusting-to-ovals-in-xfinity-series.webp "Shane van Gisbergen discusses what he learns racing on ovals in the NASCAR Xfinity Series on a week-to-week basis.")
_hsn-124-innovation-event-featuring-hp-electronics-09-18-2016-01-pm.webp "HSN")
_the-kent-politics-show-friday-10th-may-2024.webp "Catch up on the latest political news from across Kent with Gabriel Morris joined by Claire Pearsall a Conservative commentator from Sevenoaks and Labour's Cllr Shane Mochrie-Cox, Deputy Leader of Gravesham Borough Council.")
_hsn-124-hi-tech-home-05-18-2018-03-am.webp "HSNtv")
_hsn-124-tech-talk-featuring-hp-01-30-2021-02-am.webp "HSNtv")
_fda-new-drug-application-in-the-works-for-this-innovator-in-adhd-drug-delivery.webp "Shane Schaffer, Chairman & CEO, and Peter J. Werth, Board Member of Cingulate, were recently guests on Benzinga's All Access.<br/><br/>Cingulate is a biotechnology company that is developing drugs for a range of underserved conditions. The company has developed a proprietary technology called Precision Timed Release™ (PTR™). The technology allows a single pill to contain multiple doses of a drug, allowing for relief of the pill burden many people with chronic conditions suffer.<br/><br/>The company is preparing an application for new drug approval for its lead candidate, CTx-1301.")
_hsn-124-innovation-event-featuring-hp-electronics-09-18-2016-01-am.jpg)
_hsn-124-tech-talk-featuring-hp-01-30-2021-10-pm.jpg)
_hsn-124-innovation-event-featuring-hp-electronics-09-18-2016-01-pm.jpg)
_the-kent-politics-show-friday-10th-may-2024.jpg)
_hsn-124-hi-tech-home-05-18-2018-03-am.jpg)
_hsn-124-tech-talk-featuring-hp-01-30-2021-02-am.jpg)
_fda-new-drug-application-in-the-works-for-this-innovator-in-adhd-drug-delivery.jpg)
![[+]](/images/menu.gif){kind=small}